Infectious Diseases News and Research

RSS

MEMS: Sensors made for automobiles are being used for healthcare devices

MEMS industry execs attending the annual MEMS Executive Congress last week were rapt by presentations and panel discussions by leading innovators in automotive, bio/medical, consumer electronics, mobile communications and energy. Buoyed by optimistic forecasts for microelectromechanical systems (MEMS) devices such as accelerometers and multi-axis gyros—increasingly used in mobile handsets and video games—they engaged with keynote speaker Dr. Mauro Ferrari, professor and director of The Division of NanoMedicine and Deputy Chairman of The University of Texas Department of Biomedical Engineering, whose proteomic NanoChips and multi-stage drug-delivery systems may one day ‘cure cancer.’

17 Nov 2009

FDA to change its policy regarding the post-harvest processing of raw Gulf Coast oysters

Several weeks ago, the FDA announced its intent to change, by summer 2011, its policy regarding the post-harvest processing of raw Gulf Coast oysters harvested in the warmer months.

17 Nov 2009

Healthy adults may have better immunity to 2009 H1N1 influenza virus, says study

A new study shows that molecular similarities exist between the 2009 H1N1 influenza virus and other strains of seasonal H1N1 virus that have been circulating in the population since 1988. These results suggest that healthy adults may have a level of protective immune memory that can blunt the severity of infection caused by the 2009 H1N1 influenza virus.

17 Nov 2009

Live Facebook chat on H1N1 flu

People who have questions about the H1N1 flu can get answers from infectious disease experts at Rush University Medical Center during a one-hour, live Facebook chat to be held on Friday, November 20 from12 p.m. until 1 p.m.

16 Nov 2009

Sequella broadens the licensed therapeutic indications of its SQ109 lead drug candidate

Sequella, Inc., a clinical-stage biopharmaceutical company focused on commercializing products to treat life-threatening infectious diseases, today announced that it amended an existing agreement with the National Institutes of Health (NIH) to significantly broaden the licensed therapeutic indications, or "field of use," for Sequella's lead drug candidate, SQ109.

16 Nov 2009

SPOT: A one-stop HIV and sexually transmitted diseases testing center for youth

In the last 10 years, the St. Louis area has seen an alarming increase in new diagnoses of HIV and sexually transmitted infections among 13-24 year-olds. Between 1997-2007, more than 50 new diagnoses of HIV were made each year among adolescents and young adults, who are often disconnected from the health-care system or support services. Nationwide, St. Louis has among the highest rates of sexually transmitted diseases in this age group.

16 Nov 2009

Inovio Biomedical reports financial results for the three and nine months ended September 30, 2009

Inovio Biomedical Corporation today reported financial results for the three and nine months ended September 30, 2009.

16 Nov 2009

Ore Pharmaceutical Holdings reports financial results and provides operational updates for third quarter 2009

Ore Pharmaceutical Holdings Inc. today reported financial results and provided an operational update for the third quarter ended September 30, 2009.

13 Nov 2009

Third quarter 2009 financial results announced by Soligenix

Soligenix, Inc., (Soligenix or the Company) (OTC Bulletin Board: SNGX), formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today its financial results for the third quarter of 2009.

13 Nov 2009

State Fund to offer a series of free seminars to help employers protect from H1N1 influenza

In response to recent fears of the H1N1 influenza and a possible pandemic, State Fund has partnered with UC Berkeley's Center for Infectious Disease and Emergency Readiness to offer a series of free seminars statewide helping employers protect their workforces and business operations.

13 Nov 2009

RERF awarded $9.7M to study the effects of atomic bomb radiation and aging on the human immune system

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded nearly $9.7 million over five years to the Radiation Effects Research Foundation (RERF), Japan, to study the effects of atomic bomb radiation and aging on the human immune system.

13 Nov 2009

Tobira Therapeutics presents data on TBR-652 at the European AIDS Conference

Tobira Therapeutics, a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious diseases, today announced pharmacokinetic data and results from two double-blind, placebo-controlled studies of TBR-652 in eighty-four healthy volunteers.

12 Nov 2009

Stapled Peptides directly inhibit the Notch transcription factor complex

Aileron Therapeutics, a biopharmaceutical company leading the development of a new class of drugs called Stapled Peptides, announced today that its collaborators, James E. Bradner, MD of the Dana-Farber Cancer Institute and the Broad Institute of Harvard and MIT, and Gregory L. Verdine, PhD, Professor of Chemistry at Harvard University, published research in Nature entitled, “Direct Inhibition of the Notch Transcription Factor Complex.”

12 Nov 2009

Canadian researchers organize clinical trials to find new treatments for H1N1 infection

An important, ground-breaking initiative is unfolding in the global critical care community in response to the H1N1 pandemic.

12 Nov 2009

Stapled Peptides can inhibit key intracellular biological targets, says new research

Aileron Therapeutics, a biopharmaceutical company leading the development of a new class of drugs called Stapled Peptides, announced today that its collaborators, James E. Bradner, MD of the Dana-Farber Cancer Institute and the Broad Institute of Harvard and MIT, and Gregory L. Verdine, PhD, Professor of Chemistry at Harvard University, published research in Nature entitled, "Direct Inhibition of the Notch Transcription Factor Complex." Results presented in the paper showed that Stapled Peptides can potently and directly inhibit the transcription factor Notch, an oncogene implicated in cancer cell proliferation and survival.

12 Nov 2009

Novel breakthrough may lead to new methods for sterilizing food and medical equipment

Got food poisoning? The cause might be bacterial spores, en extremely hardy survival form of bacteria, a nightmare for health care and the food industry and an enigma for scientists. Spore-forming bacteria, present almost everywhere in our environment, can also cause serious infectious diseases, such as tetanus, anthrax, and botulism.

12 Nov 2009

Today's opinions and editorials

"Traditional" infectious diseases — those, like flu and tuberculosis, that are caused by viruses or bacteria — are not the only aspects of health that can spread from one person to another. Taking up smoking is contagious; so is quitting. Obesity is contagious. So is happiness (Olivia Judson, 11/10).

12 Nov 2009

Academic Health Center receives 128 grants totaling nearly $35 million in federal stimulus money

Academic Health Center scientists, physicians, and research centers have attracted 128 grants totaling nearly $35 million in federal stimulus money (as of Nov. 10) since the American Recovery and Reinvestment Act was approved in February 2009. This will result in a total economic impact of more than $105 million; according to the National Institutes of Health, $1 of research funding multiplies to more than $2 of goods and services in the economy.

11 Nov 2009

Science-based health policies could prevent nearly 4m maternal, child deaths in Africa, report says

Nearly 4 million deaths among women and children in sub-Saharan Africa could be prevented annually if relatively inexpensive, "science-based health policies" reached 90 percent of families, according to an African Science Academy Development Initiative (ASADI) report (.pdf) published Monday, Nature News reports.

10 Nov 2009

Aduro BioTech raises funds through its Series A-1 financing

Aduro BioTech, a privately held biotechnology company focused on the development of therapeutic and prophylactic vaccines based on proprietary recombinant strains of the bacterium Listeria monocytogenes, today announced completion of its Series A-1 financing.

10 Nov 2009

Infectious Diseases News and Research

MEMS: Sensors made for automobiles are being used for healthcare devices

FDA to change its policy regarding the post-harvest processing of raw Gulf Coast oysters

Healthy adults may have better immunity to 2009 H1N1 influenza virus, says study

Live Facebook chat on H1N1 flu

Sequella broadens the licensed therapeutic indications of its SQ109 lead drug candidate

SPOT: A one-stop HIV and sexually transmitted diseases testing center for youth

Inovio Biomedical reports financial results for the three and nine months ended September 30, 2009

Ore Pharmaceutical Holdings reports financial results and provides operational updates for third quarter 2009

Third quarter 2009 financial results announced by Soligenix

State Fund to offer a series of free seminars to help employers protect from H1N1 influenza

RERF awarded $9.7M to study the effects of atomic bomb radiation and aging on the human immune system

Tobira Therapeutics presents data on TBR-652 at the European AIDS Conference

Stapled Peptides directly inhibit the Notch transcription factor complex

Canadian researchers organize clinical trials to find new treatments for H1N1 infection

Stapled Peptides can inhibit key intracellular biological targets, says new research

Novel breakthrough may lead to new methods for sterilizing food and medical equipment

Today's opinions and editorials

Academic Health Center receives 128 grants totaling nearly $35 million in federal stimulus money

Science-based health policies could prevent nearly 4m maternal, child deaths in Africa, report says

Aduro BioTech raises funds through its Series A-1 financing

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News